Found 11 matching trials
Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure
PHASE2Chronic graft-versus-host disease (cGvHD) is a serious condition that can h...
Location
University Health Network
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
PHASE2This study was been conducted to evaluate the safety, tolerability, and act...
Location
City of Hope National Medical Center
KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis
PHASE2This randomized, placebo-controlled phase 2 study was seeking to evaluate t...
Location
Viable Research Management_Site number 131
Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis
PHASE2This was a phase 2, open-label, single-cohort, multicenter trial of belumos...
Location
University of California, Los Angeles Medical Center_Site number 104
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
PHASE2This is a phase 2, randomized, placebo-controlled, 2-period study to evalua...
Location
Alliance Dermatology and Mohs Center
Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
PHASE2This study was performed to evaluate the safety, tolerability, activity, ph...
Location
Arrowhead Health Centers
Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213
PHASE2Extended Treatment and Follow-up of Subjects Treated with Belumosudil in St...
Location
City of Hope Site Number : 050
Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers
PHASE1This is a single-center, 2-part, non-randomized, open-label study of the dr...
Location
Quotient Sciences Ltd
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
PHASE2This is a Phase 2, randomized, multicenter study to evaluate the efficacy a...
Location
Phoenix Childrens Hospital Site Number : 154
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
PHASE2The purpose of this study is to see if taking the study drug, Belumosudil, ...
Location
University of California, Los Angeles (Site #: 71123)